Diego Lencina
About Diego Lencina
Diego Lencina is the Business Unit Lead De Inmunologã A at Bristol-Myers Squibb, with over 25 years of experience in the pharmaceutical industry.
Current Role at Bristol-Myers Squibb
Diego Lencina is currently working at Bristol-Myers Squibb as the Business Unit Lead de Inmunología. He has been leading the immunology business unit since July 2013. With extensive experience in the pharmaceutical sector, he oversees the strategic direction and operational management of the unit, focusing on immunology.
Previous Experience at Bristol-Myers Squibb
Prior to his current role, Diego Lencina worked as the Gerente de Trasplante at Bristol-Myers Squibb, from 2012 to 2013. During his tenure, he was responsible for managing transplant-related products and strategies for a year, contributing to the company's portfolio in the transplantation field.
Work at Novo Nordisk
Diego Lencina served as the Gerente de Producto Hemofilia at Novo Nordisk from 2008 to 2012. Over a span of four years, he played a pivotal role in managing products related to hemophilia, demonstrating his expertise in product management within the pharmaceutical industry.
Career at Baxter Argentina
From 1996 to 2008, Diego Lencina was the Gerente de Producto Bioprescripciones at Baxter Argentina. Over 12 years, he developed extensive experience in bioprescriptions, marking a significant period in his career where he honed his skills in product management in the biopharmaceutical sector.
Educational Background
Diego Lencina holds a Master of Business Administration degree from a program completed in one year from 2005 to 2006. He also graduated from Universidad de Morón (Oficial), where he studied for four years from 1999 to 2003. His educational background complements his extensive experience in the pharmaceutical industry.